OGC
Oak Grove Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
2,580
-450
| -15% | -$236K | 0.22% | 37 |
|
|
2025
Q1 | $1.92M | Buy |
3,030
+100
| +3% | +$63.4K | 0.4% | 30 |
|
|
2024
Q4 | $2.09M | Buy |
2,930
+950
| +48% | +$677K | 0.31% | 33 |
|
|
2024
Q3 | $2.08M | Buy |
1,980
+80
| +4% | +$84.1K | 0.34% | 28 |
|
|
2024
Q2 | $2M | Buy |
+1,900
| New | +$2M | 0.36% | 27 |
|
|
2022
Q2 | – | Sell |
-670
| Closed | -$468K | – | 73 |
|
|
2022
Q1 | $468K | Sell |
670
-300
| -31% | -$210K | 0.09% | 58 |
|
|
2021
Q4 | $613K | Sell |
970
-50
| -5% | -$31.6K | 0.11% | 62 |
|
|
2021
Q3 | $617K | Buy |
1,020
+80
| +9% | +$48.4K | 0.13% | 62 |
|
|
2021
Q2 | $525K | Buy |
940
+220
| +31% | +$123K | 0.12% | 67 |
|
|
2021
Q1 | $341K | Buy |
+720
| New | +$341K | 0.1% | 68 |
|